Growth hormone isoforms in a girl with gigantism

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 1, 1999, Pages 99-106

  Ng, Lydia L C ^a   Chasalow, Fred I ^b   Escobar, Oscar ^c   Blethen, Sandra L ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b AMUR Pharmaceuticals Inc   (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Acromegaly; Gigantism; Growth hormone

Indexed keywords

HUMAN GROWTH HORMONE; MONOCLONAL ANTIBODY; PROLACTIN;

ACROMEGALY; AFFINITY CHROMATOGRAPHY; ARTICLE; CASE REPORT; DISEASE ACTIVITY; FEMALE; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; SCHOOL CHILD; SLEEP;

CHILD; CHROMATOGRAPHY, AFFINITY; CIRCADIAN RHYTHM; FEMALE; GIGANTISM; GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; PROTEIN ISOFORMS; RADIOIMMUNOASSAY;

EID: 0032936390     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants and binding proteins. Endocr Rev 1991; 12: 424-449.
2. Lewis UJ, Sinha YN, Haro LS. Variant forms and fragments of human growth hormone in serum. Acta Paediatr 1994; 399 (Suppl): 29-31.
3. Baumann G. Molecular forms of growth hormone. In: Grave GD, Cassorla FG, eds. Disorders of Human Growth, Advances in Research and Treatment. Springfield, IL: Charles C. Thomas, 1988; 341-362.
4. Blethen SL, Albertson-Wikland K, Faklis EJ, Chasalow FI. Circulating growth hormone isoforms in girls with Turner syndrome. J Clin Endocrinol Metab 1994; 78: 1439-1443.
5. Rieu M, Girard F, Bricaire H, Binoux M. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. J Clin Endocrinol Metab 1982; 55: 147-153.
6. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press, 1966.
7. Chasalow FI, Ginzberg LJ. Laboratory aids and tolerance testing in pediatric endocrinology: a practical approach. In: Lifshitz F, ed. Pediatric Endocrinology. New York: Marcel Dekker, 1996; 861-885.
8. Blethen SL, Chasalow FI, Beck M, Cohen M. Monoclonal antibodies in the measurement of serum growth hormone: studies of authentic peptides, normal individuals and children with short stature. J Pediatr Endocrinol 1989; 3: 217-223.
9. Surowy TK, Bartholomew RM, Vanderlaan WP. Antigenic sites of human growth hormone and related molecules detected by monoclonal antibodies to human growth hormone. Mol Immunol 1984; 21: 345-352.
10. Blethen SL, Chasalow FI. Evidence for the presence of increased amounts of 20,000 dalton (20K) growth hormone (GH) in acromegaly. The Endocrine Society, New Orleans 1988: 268 (Abstract #989).
11. Ochoa R, Fonseca E, Mercado M, Galvan RE, Hernandez M, Zarate A. The magnitude of growth hormone elevation is related with the proportion of monomeric form in acromegaly. Arch Med Res 1995; 26 (Suppl): S17-21.
12. Baumann G, MacCart JG, Amburn K. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms. J Clin Endocrinol Metab 1983; 56: 946-952.
13. Baumann G, Stolar M. Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli. J Clin Endocrinol Metab 1986; 62: 789-790.
14. Mims RB, Bethune JE. Acromegaly with normal fasting growth hormone but abnormal growth hormone regulation. Ann Intern Med 1974; 81: 781-784.
15. Daggett PR, Nabarro JDN. Measurement of the 24-hour integrated plasma concentration of growth hormone in assessing the response of acromegalic patients to treatment. Clin Endocrinol 1977; 7: 437-441.
16. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979; 301: 1138-1142.
17. Daughaday WH, Starkey RH, Saltman S, Gavin JR III, Mill-Dunlap B, Heath-Monnig E. Characterization of serum growth hormone and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. J Clin Endocrinol Metab 1987; 65: 617-623.
18. Frohman LA. Editorial: Acromegaly: What constitutes optimal therapy? J Clin Endocrinol Metab 1996; 81: 443-445.